跳至主要内容
临床试验/IRCT20181030041500N2
IRCT20181030041500N2已完成2 期

Beneficial effects of N-acetylcysteine on systemic lupus erythematosus disease activityand its associated complications

Tehran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 no limit(—)
性别
All

入选标准

  • Age more than 16
  • Having lupus
  • History of using prednisone, azathioprine, mycophenolate mofetil
  • Satisfaction with participation in the study

排除标准

  • Pregnant or lactating patients
  • Having any disease at the same time
  • History of chronic infections
  • Bronchiectasis
  • Infection in last month
  • History of severe infections or frequent infections
  • Patients with excessive use of antioxidants (daily and without Prescription) and acetaminophen
  • Acute SLE flares threatening vital organs
  • People in need of treatment with intravenous cyclophosphamide
  • Patients who are candidates for biological drugs rituximab, abatacept
  • Dissatisfaction for participation in the study

研究者

相似试验